Moderna’s mRNA Flu Vaccine Back Under FDA Review

THURSDAY, Feb. 19, 2026— In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine. The move comes just one week after the agency refused to evaluate the company’s appli...